phrykt

Geron Corp (GERN): who owns it and who trades it

As of Nov 16, 2026, GERN insiders reported 1 open-market sale worth $19.1K and 2 purchases worth $62.1K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Michelle Robertson (CFO), with $19.1K. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Geron

From the latest filings

Overall: about as much buying as selling. Famous investors mostly sold. Insiders mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns GERN

258 funds and institutions reported GERN shares worth $631M at the end of Q2 2026, about 77% of the company. The largest holder is BlackRock, Inc. with 7.7%.

Funds and institutions (13F) 77%Everyone else 23%

10 largest owners, by share of the company

BlackRock, Inc.7.7%
Ra Capital Management, L.P.6.7%
Soleus Capital Management, L.P.6.7%
State Street Corp5.6%
Citadel Advisors LLC4.5%
Vanguard Capital Management LLC4.2%
Nantahala Capital Management, LLC3.8%
Clearbridge Investments, LLC3.1%
Eversept Partners, LP2.9%
Goldman Sachs Group Inc2.6%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.49.12M7.66%$62.9M+4%
Ra Capital Management, L.P.42.81M6.67%$54.8M-33%
Soleus Capital Management, L.P.42.81M6.67%$54.8M+3%
State Street Corp35.86M5.59%$45.9M+18%
Citadel Advisors LLC29.04M4.53%$37.2M+35%
Vanguard Capital Management LLC27.25M4.25%$34.9M+2%
Nantahala Capital Management, LLC24.45M3.81%$31.3M+118%
Clearbridge Investments, LLC19.65M3.06%$25.2M+0%
Eversept Partners, LP18.72M2.92%$24M-1%
Goldman Sachs Group Inc16.63M2.59%$21.3M+49%
Geode Capital Management, LLC14.56M2.27%$18.6M+6%
Morgan Stanley12.95M2.02%$16.6M+2%
Vanguard Portfolio Management LLC10.81M1.69%$13.8M+132%
Vivo Capital, LLC8.67M1.35%$11.1MNo change
Millennium Management LLC8.11M1.26%$10.4M+11%
Kynam Capital Management, LP6.84M1.07%$8.8MNo change
Candriam S.C.A.5.59M0.87%$7.1M+43%
FMR LLC (Fidelity)5.50M0.86%$7M-17%
Pale Fire Capital SE5.31M0.83%$6.8M+9%
Northern Trust Corp5.03M0.78%$6.4M+3%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, GERN insiders reported $62.1K of open-market purchases and $19.1K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$62.1K
2 trades, 2 people
Sales, 12 months
$19.1K
1 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 16, 2026
Filed Nov 16, 2026

Purchases and sales by month

$62.1K$62.1KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 16, 2026Timothy WilliamsVice presidentPurchase12,000$0.94$11.3KForm 4
Nov 13, 2026Harout SemerjianCEOPurchase53,500$0.95$50.8KForm 4
Feb 18, 2026Michelle RobertsonCFOSale9,855$1.94$19.1KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Harout SemerjianPresident & CEO, Director$50.8K–Nov 13, 2026
Michelle RobertsonEVP, CHIEF FINANCIAL OFFICER–$19.1KFeb 18, 2026
Timothy WilliamsEVP and Chief Legal Officer$11.3K–Nov 16, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

GERN short interest

High short interest. 10.4% of GERN shares are sold short: about 1 share in 10. Over the last 12 reports the number of shares short went down 5%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 66.95M GERN shares were sold short, 10.4% of the shares outstanding, down 10.3% from the report before. At the average daily volume of 17.06M shares, buying them all back would take about 3.9 trading days (days to cover).

Shares short, % of all shares

10.4%May 15Oct 3013.7%

Days to cover

3.9May 15Oct 3012.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202666.95M10.39%-10%17.06M3.9
Oct 15, 202674.61M11.61%+1%7.56M9.9
Sep 30, 202673.89M11.50%-11%10.00M7.4
Sep 15, 202682.62M12.86%-3%12.35M6.7
Aug 31, 202685.09M13.24%+6%7.74M11.0
Aug 14, 202680.60M12.55%+5%13.87M5.8
Jul 31, 202676.81M11.95%+10%7.76M9.9
Jul 15, 202669.92M10.90%-13%10.36M6.8
Jun 30, 202680.22M12.50%+7%17.07M4.7
Jun 15, 202674.85M11.67%+4%12.71M5.9
May 29, 202671.77M11.19%+2%9.43M7.6
May 15, 202670.15M10.94%-7%18.59M3.8

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Geron company events

Geron filed 9 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership, job cuts). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Oct 28, 2026AnnouncementGeron Corporation issued a press release announcing an update on the Phase 3 IMpactMF trial evaluating imetelstat in JAK inhibitor relapsed/refractory myleofibrosis. Filing
  3. Aug 6, 2026ResultsReleased financial results. Filing
  4. May 27, 2026LeadershipAmendment to 2018 Equity Incentive Plan As further described below, at the 2026 Annual Meeting of Stockholders of Geron Corporation held on May 20, 2026, the Company’s stockholders approved an amendment and restatement of the Company’s 2018 Equity Incentive Plan to, among other items, increase the… Filing
  5. Mar 26, 2026LeadershipThe Board of Directors of Geron Corporation, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Patricia S. Andrews and Constantine Chinoporos to the Board, in each case effective immediately, and each as a Class III director for a term expiring at… Filing
  6. Feb 25, 2026ResultsReleased financial results. Filing
  7. Jan 12, 2026AnnouncementShared information with investors. Filing
  8. Jan 6, 2026AgreementGeron Corporation entered into that certain first amendment to loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a “Lender”), which are investment funds managed by Pharmakon Advisors, LP, and BioPharma Credit PLC, as collateral agent, which amends… Filing
  9. Dec 16, 2025Job cutsAnnounced job cuts or other exit costs. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Geron financials

Famous investors that hold GERN

3 of the 50 well-known investors we track reported holding GERN in their latest 13F filing. The largest position is Ken Griffin's, worth $29.9M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202624.30M$29.9M0.0%-16%
Jim Simons · Renaissance TechnologiesQ3 20264.55M$5.6M0.0%-1%
Israel Englander · Millennium ManagementQ3 20264.46M$5.5M0.0%-45%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named GERN in the last 120 days.

FiledHolderFormStake
Nov 10, 2026STATE STREET CORPORATION13G5.0%
Nov 10, 2026STATE STREET CORPORATION13G5.0%

Questions about Geron Corp (GERN) stock

Who owns the most GERN stock?

The largest reported owner of Geron Corp (GERN) is BlackRock, Inc., with 7.7% of the company. In total, 258 funds and institutions reported holding GERN at the end of Q2 2026, together about 77% of the shares. See the largest owners.

Are GERN insiders buying or selling?

In the last 12 months, GERN insiders reported 2 open-market purchases worth $62.1K and 1 sale worth $19.1K. The latest trade was on Nov 16, 2026. See every trade.

What is the short interest in GERN?

As of Oct 30, 2026, 66.95M GERN shares were sold short, 10.4% of the shares outstanding, down 10.3% from the report before. At the average daily volume of 17.06M shares, buying them all back would take about 3.9 trading days (days to cover). See the history.

Which famous investors hold GERN?

3 of the 50 well-known investors we track reported GERN in their latest 13F filing, including Ken Griffin, Jim Simons, Israel Englander. The largest position is worth $29.9M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.